These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1253368)

  • 21. The effect of hyperosmotic mannitol and glucose on heart function.
    Pogátsa G; Dubecz E
    Endokrinologie; 1979; 73(3):328-35. PubMed ID: 499101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hyperosomotic mannitol in reducing ischemic swelling and minimizing myocardial necrosis. Discussion.
    Willerson JT
    Circulation; 1976 Mar; 53(3 Suppl):I49-51. PubMed ID: 45826
    [No Abstract]   [Full Text] [Related]  

  • 24. Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog.
    Willerson JT; Watson JT; Hutton I; Templeton GH; Fixler DE
    Circ Res; 1975 Jun; 36(6):771-81. PubMed ID: 1132070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.
    Jolly SR; Hardman HF; Gross GJ
    J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of mannitol on the postischemic kidney. Biochemical, functional, and morphologic assessments.
    Zager RA; Mahan J; Merola AJ
    Lab Invest; 1985 Oct; 53(4):433-42. PubMed ID: 3930877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial cell volume and coronary resistance during diminished coronary perfusion.
    Powers ER; DiBona DR; Powell WJ
    Am J Physiol; 1984 Sep; 247(3 Pt 2):H467-77. PubMed ID: 6433726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of drug intervention on the ischemic myocardium: serial imaging and measurement with computerized tomography.
    Powell WJ; Wittenberg J; Miller SW; Maturi RA; Dinsmore RE
    Am J Cardiol; 1979 Jul; 44(1):46-52. PubMed ID: 453045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No-reflow phenomenon and acute myocardial ischemia. The need for further investigation.
    Camilleri JP; Fabiani JN
    Biomedicine; 1977 Dec; 26(6):353-6. PubMed ID: 606301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin (Fab')2.
    Frame LH; Lopez JA; Khaw BA; Fallon JT; Haber E; Powell WJ
    J Clin Invest; 1983 Aug; 72(2):535-44. PubMed ID: 6223942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of mannitol to obviate propranolol-induced myocardial depression in ischemic canine heart.
    Kyriakidis G; Barletta M
    J Pharm Sci; 1980 Apr; 69(4):447-51. PubMed ID: 6768876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities of volume regulation and membrane integrity in myocardial tissue slices after early ischemic injury in the dog: effects of mannitol, polyethylene glycol, and propranolol.
    Buja LM; Willerson JT
    Am J Pathol; 1981 Apr; 103(1):79-95. PubMed ID: 6784578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute.
    Flores J; DiBona DR; Beck CH; Leaf A
    J Clin Invest; 1972 Jan; 51(1):118-26. PubMed ID: 5007042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow.
    Kloner RA; Ganote CE; Whalen DA; Jennings RB
    Am J Pathol; 1974 Mar; 74(3):399-422. PubMed ID: 4814895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Acta Med Scand Suppl; 1976; 587():125-36. PubMed ID: 3095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of mannitol on maintaining coronary flows and salvaging myocardium during ventriculotomy and during prolonged coronary artery ligation.
    Fixler DE; Buja LM; Wheeler JM; Willerson JT
    Circulation; 1977 Sep; 56(3):340-6. PubMed ID: 884788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic evaluation of agents designed to protect the ischemic myocardium and to reduce infarct size.
    Brachfeld N
    Am J Cardiol; 1976 Mar; 37(4):528-32. PubMed ID: 1258790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of mannitol on cardiac ultrastructure and microcirculation following anoxia.
    Christodoulou J; Erlandson R; Smithen C; Killip T; Brachfeld N
    Am J Physiol; 1975 Sep; 229(3):853-60. PubMed ID: 1211478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary reperfusion: effects of hyperosmotic mannitol.
    Parker PE; Bashour FA; Downey HF; Boutros IS
    Am Heart J; 1979 Jun; 97(6):745-52. PubMed ID: 433751
    [No Abstract]   [Full Text] [Related]  

  • 40. Cellular swelling and irreversible myocardial injury. Effects of polyethylene glycol and mannitol in perfused rat hearts.
    Ganote CE; Worstell J; Iannotti JP; Kaltenbach JP
    Am J Pathol; 1977 Jul; 88(1):95-118. PubMed ID: 879272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.